1. Dear Drugs-Forum readers: We are a small non-profit that runs one of the most read drug information & addiction help websites in the world. We serve over 4 million readers per month, and have costs like all popular websites: servers, hosting, licenses and software. To protect our independence we do not run ads. We take no government funds. We run on donations which average $25. If everyone reading this would donate $5 then this fund raiser would be done in an hour. If Drugs-Forum is useful to you, take one minute to keep it online another year by donating whatever you can today. Donations are currently not sufficient to pay our bills and keep the site up. Your help is most welcome. Thank you.

Dextromethorphan Potentiates the Antinociceptive Effects of Morphine and the mu-Opioid Agonist SNC80

Dextromethorphan Potentiates the Antinociceptive Effects of Morphine and the mu-Opioid Agonist SNC80

  1. davestate
    The American Society for Pharmacology and Experimental Therapeutics: 300:435–441, 2002


    ABSTRACT: Dextromethorphan (DXM) is a noncompetitive N-methyl-D-aspartate(NMDA) receptor antagonist shown to prevent the development of tolerance to the antinociceptive effects of morphine in rodents. DXM also potentiates the antinociceptive effects of the mu-opioid receptor agonist morphine under some conditions; however, the effect of DXM in combination with opioids other than morphine has not been well characterized.This study determined the antinociceptive effects of DXM administered alone or in combination with morphine or the mu-opioid receptor (DOR) agonist SNC80 using a squirrel monkey titration procedure. In this procedure, shock (delivered to the tail) increases in intensity every 15 s (0.01–2.0 mA) in 30 increments.Five lever presses during any given 15-s shock period produces a 15-s shock-free period after which shock resumes at the next lower intensity. This assay provides a measure of antinociception that is separable from motor effects [responserate (RR)]. Morphine (0.3–3.0 mg/kg i.m.) and SNC80 (1.0–10mg/kg i.m.), but not DXM (1.0–10 mg/kg i.m.) dose- and time dependently increased the intensity below which monkeys (n 4) maintained shock 50% of the time [median shock level(MSL)]. Doses of morphine and SNC80 that alone did not increase MSL were potentiated by DXM. Importantly, these combinations did not significantly alter RR. These data support previous findings with other NMDA receptor antagonists and morphine using this procedure and also extend those findings to a DOR agonist.

    "Please create discussion thread"